22.418 articles found

USE OF FINASTERIDE, DUTASTERIDE AND RELATED COMPOUNDS FOR THE PREVENTION OR TREATMENT OF NEUROLOGICALLY-ASSOCIATED DISORDERS

SOSKIC Vukic, SCHRATTENHOLZ André.

· 2005-12-02

USE OF FINASTERIDE, DUTASTERIDE AND RELATED COMPOUNDS FOR THE PREVENTION OR TREATMENT OF NEUROLOGICALLY-ASSOCIATED DISORDERS

SOSKIC VUKIC, SCHRATTENHOLZ ANDRE.

· 2005-12-02

Adeno-associated virus vectors: potential applications for cancer gene therapy.

Li C, Bowles DE, van Dyke T, Samulski RJ.

Cancer Gene Ther · 2005-12-01

DOI: 10.1038/sj.cgt.7700876PMID: 15962012

Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.

Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, Montastruc JL, Rascol O.

Mov Disord · 2005-12-01

DOI: 10.1002/mds.20629PMID: 16078219

Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.

Thomas A, Onofrj M.

Mov Disord · 2005-12-01

DOI: 10.1002/mds.20689PMID: 16149099

The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.

Gaeta A, Hider RC.

Br J Pharmacol · 2005-12-01

DOI: 10.1038/sj.bjp.0706416PMID: 16205720

Imaging in cell-based therapy for neurodegenerative diseases.

Kirik D, Breysse N, Björklund T, Besret L, Hantraye P.

Eur J Nucl Med Mol Imaging · 2005-12-01

DOI: 10.1007/s00259-005-1909-6PMID: 16267643

[Medication treatment for Parkinson's disease].

Reichmann H.

Nervenarzt · 2005-12-01

DOI: 10.1007/s00115-005-2009-3PMID: 16283151

Drug-induced delusions of parasitosis during treatment of Parkinson's disease.

Swick BL, Walling HW.

J Am Acad Dermatol · 2005-12-01

DOI: 10.1016/j.jaad.2005.06.040PMID: 16310077

[Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)].

Mínguez-Castellanos A, Escamilla-Sevilla F.

Rev Neurol · 2005-12-01

DOI: 10.33588/rn.4110.2005245PMID: 16317638

Banana juice reduces bioavailability of levodopa preparation.

Ogo Y, Sunagane N, Ohta T, Uruno T.

Yakugaku Zasshi · 2005-12-01

DOI: 10.1248/yakushi.125.1009PMID: 16327247

The assays of activities and function of TH, AADC, and GCH1 and their potential use in ex vivo gene therapy of PD.

Duan CL, Su Y, Zhao CL, Lu LL, Xu QY, Yang H.

Brain Res Brain Res Protoc · 2005-12-01

DOI: 10.1016/j.brainresprot.2005.10.005PMID: 16338639